# FDA Inspection 1160764 - Octapharma Plasma Inc - November 05, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/617709ab-63d3-43ea-bd23-a5552ae54705
Source feed: FDA_Inspections

> FDA Inspection 1160764 for Octapharma Plasma Inc on November 05, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160764
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-11-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1280336 - 2025-08-20](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/52b5ec57-acf6-445d-a662-32477504e0df)
- [FDA Inspection 1280336 - 2025-08-20](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/a6b1777b-0f6e-421b-81c3-b8dc2b3697f0)
- [FDA Inspection 1160764 - 2021-11-05](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/428da3cd-bf20-426b-b026-d29293462f24)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/6565c5b0-a5ca-4ddc-aee9-b5afd578801e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d